PERCEPTIVE ADVISORS LLC's Q3 2026 13F: 23 new positions, 25 exits
Form 13F-HR for the quarter ended Sep 30, 2026 · filed Nov 16, 2026 · 99 reported positions · accession 0001012975-26-001063
What changed this quarter
| Activity | Security | Weight before | Weight now | Change | Shares | Shares % |
|---|---|---|---|---|---|---|
| New | FREENOME INC (FRNM) | — | 3.7% | +3.7 pts | +12.61M sh | new |
| Exited | NUVALENT INC (NUVL) | 3.0% | — | −3.0 pts | −1.58M sh | −100% |
| Exited | APOGEE THERAPEUTICS INC (APGE) | 2.7% | — | −2.7 pts | −1.31M sh | −100% |
| Reduced | SPYRE THERAPEUTICS INC (SYRE) | 6.0% | 5.5% | −0.5 pts | −1.04M sh | −24% |
| Increased | AMYLYX PHARMACEUTICALS INC (AMLX) | 2.3% | 5.8% | +3.4 pts | +2.24M sh | +27% |
| New | WATERS CORP (WAT) | — | 1.1% | +1.1 pts | +135K sh | new |
| Reduced | ROIVANT SCIENCES LTD (ROIV) | 4.5% | 4.5% | 0.0 pts | −1.57M sh | −19% |
| Reduced | BIOGEN INC (BIIB) | 0.9% | 0.1% | −0.8 pts | −248K sh | −90% |
| Reduced | ASCENDIS PHARMA A/S (ASND) | 4.8% | 4.2% | −0.7 pts | −192K sh | −17% |
| New | OPUS GENETICS INC (OCUP) | — | 0.8% | +0.8 pts | +9M sh | new |
| Reduced | UNITEDHEALTH GROUP INC (UNH) | 0.8% | 0.1% | −0.7 pts | −107K sh | −91% |
| Exited | IONIS PHARMACEUTICALS INC (IONS) | 0.7% | — | −0.7 pts | −566K sh | −100% |
| New | LAKEFRONT BIOTHERAPEUTICS NV (LKFT) | — | 0.7% | +0.7 pts | +1.24M sh | new |
| New | ABBOTT LABORATORIES (ABT) | — | 0.6% | +0.6 pts | +345K sh | new |
| Exited | JAZZ PHARMACEUTICALS PLC (JAZZ) | 0.6% | — | −0.6 pts | −170K sh | −100% |
| New | BLOSSOMHILL THERAPEUTICS INC (BLSM) | — | 0.6% | +0.6 pts | +1.81M sh | new |
| Exited | SIONNA THERAPEUTICS INC (SION) | 0.6% | — | −0.6 pts | −905K sh | −100% |
| Exited | CORCEPT THERAPEUTICS INC (CORT) | 0.5% | — | −0.5 pts | −398K sh | −100% |
| Reduced | IMMUNOVANT INC (IMVT) | 0.8% | 0.3% | −0.5 pts | −838K sh | −62% |
| Exited | DAMORA THERAPEUTICS INC (GLTO) | 0.5% | — | −0.5 pts | −1.22M sh | −100% |
| Exited | CHARLES RIV LABS INTL INC (CRL) | 0.5% | — | −0.5 pts | −140K sh | −100% |
| New | MINIMED GROUP INC (MMED) | — | 0.5% | +0.5 pts | +1.32M sh | new |
| Increased | NURIX THERAPEUTICS INC (NRIX) | 1.6% | 2.4% | +0.8 pts | +1.05M sh | +24% |
| Reduced | RELAY THERAPEUTICS INC (RLAY) | 4.1% | 4.3% | +0.2 pts | −1.38M sh | −10% |
| Exited | AXSOME THERAPEUTICS INC. (AXSM) | 0.5% | — | −0.5 pts | −118K sh | −100% |
| Reduced | ADAPTIVE BIOTECHNOLOGIES COR (ADPT) | 0.4% | 0.2% | −0.2 pts | −805K sh | −66% |
| Reduced | DYNE THERAPEUTICS INC (DYN) | 0.9% | 0.4% | −0.5 pts | −1.42M sh | −53% |
| Reduced | ORUKA THERAPEUTICS INC (ORKA) | 2.0% | 1.7% | −0.3 pts | −273K sh | −20% |
| New | SEPTERNA INC (SEPN) | — | 0.4% | +0.4 pts | +567K sh | new |
| New | ENLIVEN THERAPEUTICS INC (ELVN) | — | 0.4% | +0.4 pts | +463K sh | new |
| Exited | TENAX THERAPEUTICS INC (TENX) | 0.4% | — | −0.4 pts | −1.7M sh | −100% |
| Reduced | PROTAGONIST THERAPEUTICS INC (PTGX) | 1.9% | 2.2% | +0.3 pts | −145K sh | −15% |
| Reduced | REVOLUTION MEDICINES INC (RVMD) | 1.5% | 1.7% | +0.1 pts | −94,500 sh | −18% |
| New | YARROW BIOSCIENCE INC (YARW) | — | 0.3% | +0.3 pts | +813K sh | new |
| Exited | INTUITIVE SURGICAL INC (ISRG) | 0.3% | — | −0.3 pts | −51,884 sh | −100% |
| Reduced | TANGO THERAPEUTICS INC (TNGX) | 1.6% | 1.3% | −0.4 pts | −684K sh | −20% |
| Exited | CONTINEUM THERAPEUTICS INC (CTNM) | 0.3% | — | −0.3 pts | −1.26M sh | −100% |
| New | SCRIBE THERAPEUTICS INC (SCTX) | — | 0.3% | +0.3 pts | +920K sh | new |
| Reduced | ZYMEWORKS INC (ZYME) | 1.7% | 1.8% | +0.1 pts | −637K sh | −15% |
| Reduced | NUVECTIS PHARMA INC (NVCT) | 0.3% | 0.1% | −0.2 pts | −760K sh | −76% |
| Reduced | DANAHER CORP DEL (DHR) | 0.4% | 0.2% | −0.1 pts | −70,000 sh | −54% |
| Exited | OMADA HEALTH INC (OMDA) | 0.3% | — | −0.3 pts | −786K sh | −100% |
| New | GRAIL INC (GRAL) | — | 0.3% | +0.3 pts | +96,911 sh | new |
| Reduced | IRHYTHM HOLDINGS INC (IRTC) | 0.4% | 0.2% | −0.2 pts | −110K sh | −49% |
| Reduced | TRAVERE THERAPEUTICS INC (TVTX) | 3.3% | 3.9% | +0.6 pts | −210K sh | −6% |
| New | VERADERMICS INC (MANE) | — | 0.2% | +0.2 pts | +97,000 sh | new |
| New | ENTERA BIO LTD (ENTX) | — | 0.2% | +0.2 pts | +3.43M sh | new |
| Reduced | EDGEWISE THERAPEUTICS INC (EWTX) | 2.8% | 3.2% | +0.4 pts | −236K sh | −5% |
| Exited | OSCAR HEALTH INC (OSCR) | 0.2% | — | −0.2 pts | −400K sh | −100% |
| Exited | BOSTON SCIENTIFIC CORP (BSX) | 0.2% | — | −0.2 pts | −250K sh | −100% |
The 50 largest of 100 changes, by size of the trade. Full holdings for this quarter.
Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled
Top 10 positions — 52.2% of the equity book
Changes in the top 10 this quarter: AMLX entered · FRNM entered · KARD left · NUVL left
| # | Security | Weight before | Weight now | |
|---|---|---|---|---|
| 1 | PRAXIS PRECISION MEDICINES I (PRAX) | 10.6% | 11.1% | |
| 2 | AMYLYX PHARMACEUTICALS INC (AMLX) | 2.3% | 5.8% | Entered the top 10 |
| 3 | SPYRE THERAPEUTICS INC (SYRE) | 6.0% | 5.5% | |
| 4 | CELCUITY INC (CELC) | 5.2% | 4.7% | |
| 5 | RHYTHM PHARMACEUTICALS INC (RYTM) | 4.5% | 4.5% | |
| 6 | ROIVANT SCIENCES LTD (ROIV) | 4.5% | 4.5% | |
| 7 | RELAY THERAPEUTICS INC (RLAY) | 4.1% | 4.3% | |
| 8 | ASCENDIS PHARMA A/S (ASND) | 4.8% | 4.2% | |
| 9 | TRAVERE THERAPEUTICS INC (TVTX) | 3.3% | 3.9% | |
| 10 | FREENOME INC (FRNM) | 0.0% | 3.7% | Entered the top 10 |
| — | KARDIGAN INC (KARD) | 3.0% | 2.3% | Left the top 10 |
| — | NUVALENT INC (NUVL) | 3.0% | 0.0% | Left the top 10 |
Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).
Option positions (puts and calls)
Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.
| Activity | Security | Type | Shares before | Shares now | Reported value |
|---|---|---|---|---|---|
| Increased | MODERNA INC (MRNA) | Put | 1M | 1.4M | $270M |
| New | SELLAS LIFE SCIENCES GROUP I (SLS) | Call | 0 | 3M | $36.9M |
| Exited | CAPRICOR THERAPEUTICS INC (CAPR) | Call | 1M | 0 | $0 |
| Increased | EYEPOINT INC (EYPT) | Put | 2M | 3.5M | $11.4M |
| Reduced | SPDR SERIES TRUST (XBI) | Put | 300K | 200K | $31.5M |
| Exited | CAPRICOR THERAPEUTICS INC (CAPR) | Put | 500K | 0 | $0 |
| Increased | SELLAS LIFE SCIENCES GROUP I (SLS) | Put | 1.5M | 2.5M | $30.8M |
| New | BIOHAVEN LTD (BHVN) | Put | 0 | 200K | $2.67M |
| New | EYEPOINT INC (EYPT) | Call | 0 | 725K | $2.37M |
| Increased | NEWAMSTERDAM PHARMA COMPANY (NAMS) | Put | 500K | 600K | $14.6M |